BACKGROUND: Pleural dissemination of @entity1725 ( @entity1725 ) is considered an advanced/terminal disease. We review our experience with thoracic @entity1104 ( @entity1104 ) and intraoperative hyperthermic intrathoracic chemotherapy (HITHOC) for the treatment of pleural recurrence of @entity1725 following previous intraabdominal surgery. @entity1 AND METHODS: An observational study of five @entity1 with @entity1143 from @entity1725 treated with thoracic @entity1104 and intraoperative HITHOC with @entity1138 for 90 min at 41.5 degrees C. RESULTS: There were three @entity1 . The mean age was 46.5 (10.5) years. Postoperatively, one @entity1 developed Grade I, one @entity1 developed Grade III and one @entity1 developed @entity260 . Two @entity1 had an unremarkable postoperative recovery. Only one @entity1 has died 38 months since treatment from abdominal complication of this disease with no evidence of @entity1514 . The four surviving @entity1 are still alive 4.6-47.4 months after treatment. Two @entity1 have evidence of an intraabdominal recurrence. CONCLUSIONS: Thoracic @entity1104 and intraoperative HITHOC is a safe and effective procedure to treat @entity1143 from @entity1725 . Long-term disease-free survival can be achieved from this treatment for which no other potentially curative therapy has been described.

Thoracic @entity1104 and intraoperative hyperthermic intrathoracic chemotherapy for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS', 'men'] @entity1143 :: ('MESH:D010996', 'Disease') :: ['pleural dissemination'] @entity1138 :: ('MESH:D016685', 'Chemical') :: ['mitomycin C'] @entity1514 :: ('MESH:D013896', 'Disease') :: ['thoracic disease'] @entity260 :: ('MESH:D011183', 'Disease') :: ['Grade IV postoperative complication'] @entity1725 :: ('MESH:D011553', 'Disease') :: ['PMP', 'pseudomyxoma peritonei'] @entity1104 :: ('MESH:D000267', 'Disease') :: ['CRS', 'cytoreductive surgery']
@entity1725 :: (MESH:D011553,Disease) :: ['pseudomyxoma peritonei']
